{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:50:24Z","timestamp":1792651824547,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.transproceed.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T22:28:35Z","timestamp":1604615315000},"page":"244-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Course of Ulcerative Colitis After Pediatric Liver Transplantation for Sclerosing Cholangitis"],"prefix":"10.1016","volume":"53","author":[{"given":"Marcin","family":"Osiecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Kierku\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Paw\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Teisseyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"D\u0105dalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Jarz\u0119bicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Stefanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czubkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.09.011_bib1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/lt.24490","article-title":"Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation","volume":"22","author":"Liberal","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.09.011_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.transproceed.2020.09.011_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2020.09.011_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/lt.22320","article-title":"Pediatric liver transplantation for primary sclerosing cholangitis","volume":"17","author":"Miloh","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.09.011_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"J\u00f8rgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2020.09.011_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","article-title":"The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.09.011_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.23741","article-title":"Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/lt.21077","article-title":"Combined HLA-DR and-DQ disparity associated with stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis","volume":"13","author":"Cholongitas","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.09.011_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2020.09.011_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation---a single-center experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e3283388f5b","article-title":"Unique features of primary sclerosing cholangitis in children","volume":"26","author":"Mieli-Vergani","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.transproceed.2020.09.011_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cld.2015.08.008","article-title":"Sclerosing cholangitis in children and adolescents","volume":"20","author":"Mieli-Vergani","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.transproceed.2020.09.011_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.transproceed.2020.09.011_bib18","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification","volume":"17","author":"Levine","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.transproceed.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01318204","article-title":"Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis","volume":"36","author":"Gavaler","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007890-199802150-00017","article-title":"Clinical course and management of inflammatory bowel disease after liver transplantation","volume":"65","author":"Befeler","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2020.09.011_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/gut.43.5.639","article-title":"Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis","volume":"43","author":"Papatheoridis","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.transproceed.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00042737-200512000-00018","article-title":"The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation","volume":"17","author":"Ho","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2020.09.011_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/00365521.2012.685754","article-title":"Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study","volume":"47","author":"J\u00f8rgensen","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MPG.0000000000002036","article-title":"Management of paediatric ulcerative colitis, part 2: acute severe colitis---an evidence-based consensus guideline from the European Crohn\u2019s and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"67","author":"Turner","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.transproceed.2020.09.011_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2020.09.011_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ajg.2010.33","article-title":"Anti-tumor necrosis factor therapy for inflammatory bowel disease in setting of immunosuppression for solid organ transplantation","volume":"105","author":"El-Nachef","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.2012.05141.x","article-title":"The safety and efficacy of anti tumor necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series","volume":"36","author":"Sandhu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2020.09.011_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0b013e3280116ccc","article-title":"Infliximab for ulcerative colitis following liver transplantation","volume":"19","author":"Lal","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2020.09.011_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2036.2012.05217.x","article-title":"Antitumour necrosis factor treatment of inflammatory bowel disease in liver transplantation recipients","volume":"36","author":"Mohabbat","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2020.09.011_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/ecco-jcc\/jjv182","article-title":"Management of ulcerative colitis using vedolizumab after liver transplantation for primary sclerosing cholangitis","volume":"10","author":"Meszaros","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.transproceed.2020.09.011_bib34","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2020.09.011_bib35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520304681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134520304681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:38:49Z","timestamp":1758577129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134520304681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0041134520304681"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.09.011","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Course of Ulcerative Colitis After Pediatric Liver Transplantation for Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}